Embree Financial Group

Position in BSX — Boston Scientific Corp

CIK 2020860 Chicago, IL

Position in BSX

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$291,411

New position

Shares Held

4,644

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Embree Financial Group holds $3,748,345 across 4 Medical Devices names. BSX ranks #2 (7.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	30,758	$3,157,923
2	BSX	Boston Scientific Corp This page	4,644	$291,411
3	SYK	Stryker Corp	687	$225,741
4	TELA	TELA Bio, Inc.	118,178	$73,270

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$291,411	4,644	—	Shares	Sole	2026-04-24
No filing history on record for this holder in this stock.